News
- Author:
- Andrew D. Bowser
Publish date: July 15, 2021
Preexisting autoimmune cytopenias frequently improved or resolved on ibrutinib, idelalisib, or venetoclax, while ...
News
- Author:
- Andrew D. Bowser
Publish date: July 1, 2021
Statistically significant reductions in A1c and diabetes distress were seen in the Praise Diabetes Project, a 33-month randomized trial, an investi...
News
- Author:
- Andrew D. Bowser
Publish date: July 1, 2021
Results suggest a need to be “very careful” with treatment choice in certain patients, investigator says, though much more research is needed to ex...
News
- Author:
- Andrew D. Bowser
Publish date: June 29, 2021
Infusing diabetes education with concepts and lingo from car culture is a promising approach to improving self-management behaviors, and might also...
News
- Author:
- Andrew D. Bowser
Publish date: June 27, 2021
Program adds support for children with diabetes and their families who are struggling because of lack of resources or marginalization in the health...
News
- Author:
- Andrew D. Bowser
Publish date: June 27, 2021
Coupled with renal and A1c data, the findings suggest improved prognosis for these patients, Swedish investigators say.
News
- Author:
- Andrew D. Bowser
Publish date: June 26, 2021
Findings suggest in part that hospitalized COVID-19 patients need aggressive treatment of hyperglycemia, regardless of the diagnosis of diabetes or...
News
- Author:
- Andrew D. Bowser
Publish date: June 22, 2021
Nasal antihistamines “work quickly, whereas the nasal steroids don’t, and I think a lot of people who go to the drugstore looking for allergy relie...
News
- Author:
- Andrew D. Bowser
Publish date: June 11, 2021
Responses with patritumab deruxtecan were seen across a spectrum of resistance mutations among patients wi...
News
- Author:
- Andrew D. Bowser
Publish date: June 10, 2021
Combined with pathologic complete response data reported previously, findings of CheckMate 816 build a case for c...
News
- Author:
- Andrew D. Bowser
Publish date: June 10, 2021
The increasing use of immuno-oncology approaches and new clinical trials are pushing cytotoxic chemotherapy to la...
News
- Author:
- Andrew D. Bowser
Publish date: June 6, 2021
Subgroup analyses suggest benefit even in patients with co-occurring mutations usually associated with poor respo...
News
- Author:
- Andrew D. Bowser
Publish date: June 6, 2021
Patients are missing the opportunity to be considered for FDA-approved therapies and clinical trials, the retrosp...
News
- Author:
- Andrew D. Bowser
Publish date: June 6, 2021
Results of the exploratory analyses are hypothesis generating but suggest a link between treatment-emergent adver...
News
- Author:
- Andrew D. Bowser
Publish date: May 28, 2021
Loose stools, somatization, and chronic fatigue risks increased at a mean of 5 months after SARS-CoV-2 infection, suggesting a common postinfectiou...
